Imugene Limited (IMU.AX)
AUD 0.04
(-5.26%)
AUD 0.04
(-5.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -147.97 Million AUD | -212.02% |
| 2023 | -47.42 Million AUD | -1.71% |
| 2022 | -48.06 Million AUD | -103.62% |
| 2021 | -23.71 Million AUD | -60.2% |
| 2020 | -14.55 Million AUD | -20.05% |
| 2019 | -11.83 Million AUD | -113.42% |
| 2018 | -5.77 Million AUD | -56.8% |
| 2017 | -3.66 Million AUD | 13.7% |
| 2016 | -4.24 Million AUD | -63.48% |
| 2015 | -194.89 Thousand AUD | -834.42% |
| 2014 | -2.62 Million AUD | 120.44% |
| 2013 | -1.74 Million AUD | -258.96% |
| 2012 | -995.32 Thousand AUD | 60.37% |
| 2011 | 682.09 Thousand AUD | 138.32% |
| 2010 | -1.42 Million AUD | 26.27% |
| 2009 | 595.67 Thousand AUD | -8.93% |
| 2008 | -1.8 Million AUD | 4.54% |
| 2007 | -2.69 Million AUD | 17.24% |
| 2006 | -2.09 Million AUD | -29.57% |
| 2005 | -1.96 Million AUD | -33.89% |
| 2004 | -1.61 Million AUD | 29.57% |
| 2003 | -2.29 Million AUD | -85.83% |
| 2002 | 1.11 Million AUD | 63.88% |
| 2001 | -3.42 Million AUD | 22.27% |
| 2000 | -4.4 Million AUD | 10.24% |
| 1999 | -4.9 Million AUD | -8.52% |
| 1998 | -4.51 Million AUD | -113.72% |
| 1997 | -2.11 Million AUD | 49.02% |
| 1996 | -4.14 Million AUD | -174.09% |
| 1995 | -1.51 Million AUD | -73.71% |
| 1994 | -871 Thousand AUD | -185.57% |
| 1993 | -305 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -67.55 Million AUD | 0.0% |
| 2024 FY | - AUD | -175.19% |
| 2024 Q2 | -69.15 Million AUD | 0.0% |
| 2023 FY | - AUD | -1.71% |
| 2023 Q4 | -20.5 Million AUD | 0.0% |
| 2023 Q2 | -16.76 Million AUD | 0.0% |
| 2022 Q4 | -21.35 Million AUD | 0.0% |
| 2022 FY | - AUD | -103.62% |
| 2022 Q2 | -14.09 Million AUD | 0.0% |
| 2021 FY | - AUD | -60.2% |
| 2021 Q2 | -10.14 Million AUD | 0.0% |
| 2021 Q4 | -10.5 Million AUD | 0.0% |
| 2020 Q2 | -4.87 Million AUD | 0.0% |
| 2020 FY | - AUD | -20.05% |
| 2020 Q4 | -5.84 Million AUD | 0.0% |
| 2019 Q2 | -3.7 Million AUD | 0.0% |
| 2019 FY | - AUD | -113.42% |
| 2019 Q4 | -6.99 Million AUD | 0.0% |
| 2018 Q2 | -1.64 Million AUD | 0.0% |
| 2018 FY | - AUD | -56.8% |
| 2018 Q4 | -2.28 Million AUD | 0.0% |
| 2017 Q2 | -1.48 Million AUD | 0.0% |
| 2017 FY | - AUD | 13.7% |
| 2017 Q4 | -1.03 Million AUD | 0.0% |
| 2016 FY | - AUD | -63.48% |
| 2016 Q4 | -1.62 Million AUD | 0.0% |
| 2016 Q2 | -1.07 Million AUD | 0.0% |
| 2015 Q2 | -42.57 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -834.42% |
| 2015 Q4 | -152.32 Thousand AUD | 0.0% |
| 2014 Q2 | -534.54 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 120.44% |
| 2014 Q4 | -262.27 Thousand AUD | 0.0% |
| 2013 Q3 | -389.72 Thousand AUD | 65.3% |
| 2013 Q4 | -408.26 Thousand AUD | -4.76% |
| 2013 Q2 | -1.12 Million AUD | -51.73% |
| 2013 Q1 | -740.33 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -258.96% |
| 2012 FY | - AUD | 60.37% |
| 2012 Q4 | -740.33 Thousand AUD | 0.0% |
| 2012 Q3 | -740.33 Thousand AUD | 0.0% |
| 2012 Q2 | -740.33 Thousand AUD | -668.75% |
| 2012 Q1 | 130.16 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 138.32% |
| 2011 Q4 | 130.16 Thousand AUD | 0.0% |
| 2011 Q3 | 130.16 Thousand AUD | 0.0% |
| 2011 Q2 | 130.16 Thousand AUD | 136.57% |
| 2011 Q1 | -355.97 Thousand AUD | 0.0% |
| 2010 Q1 | 148.41 Thousand AUD | 0.0% |
| 2010 Q2 | -355.97 Thousand AUD | -339.86% |
| 2010 Q4 | -355.97 Thousand AUD | 0.0% |
| 2010 Q3 | -355.97 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 26.27% |
| 2009 Q2 | 148.41 Thousand AUD | 132.82% |
| 2009 Q4 | 148.41 Thousand AUD | 0.0% |
| 2009 Q3 | 148.41 Thousand AUD | 0.0% |
| 2009 FY | - AUD | -8.93% |
| 2009 Q1 | -452.13 Thousand AUD | 0.0% |
| 2008 Q1 | -555.04 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 4.54% |
| 2008 Q4 | -452.13 Thousand AUD | 0.0% |
| 2008 Q3 | -452.13 Thousand AUD | 0.0% |
| 2008 Q2 | -452.13 Thousand AUD | 18.54% |
| 2007 Q2 | -555.04 Thousand AUD | -6.09% |
| 2007 Q4 | -555.04 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 17.24% |
| 2007 Q1 | -523.15 Thousand AUD | 0.0% |
| 2007 Q3 | -555.04 Thousand AUD | 0.0% |
| 2006 Q3 | -523.15 Thousand AUD | 0.0% |
| 2006 FY | - AUD | -29.57% |
| 2006 Q4 | -523.15 Thousand AUD | 0.0% |
| 2006 Q2 | -523.15 Thousand AUD | 41.38% |
| 2006 Q1 | -892.5 Thousand AUD | 0.0% |
| 2005 FY | - AUD | -33.89% |
| 2005 Q4 | -892.5 Thousand AUD | 0.0% |
| 2005 Q1 | -642.05 Thousand AUD | 0.0% |
| 2005 Q3 | -892.5 Thousand AUD | 0.0% |
| 2005 Q2 | -892.5 Thousand AUD | -39.01% |
| 2004 FY | - AUD | 29.57% |
| 2004 Q3 | -642.05 Thousand AUD | 0.0% |
| 2004 Q2 | -642.05 Thousand AUD | -90.94% |
| 2004 Q1 | -336.26 Thousand AUD | 0.0% |
| 2004 Q4 | -642.05 Thousand AUD | 0.0% |
| 2003 Q4 | -336.26 Thousand AUD | 0.0% |
| 2003 FY | - AUD | -85.83% |
| 2003 Q3 | -336.26 Thousand AUD | 0.0% |
| 2003 Q1 | -308.92 Thousand AUD | 0.0% |
| 2003 Q2 | -336.26 Thousand AUD | -8.85% |
| 2002 Q1 | -1.86 Million AUD | 0.0% |
| 2002 Q3 | -308.92 Thousand AUD | 0.0% |
| 2002 FY | - AUD | 63.88% |
| 2002 Q2 | -308.92 Thousand AUD | 83.44% |
| 2002 Q4 | -308.92 Thousand AUD | 0.0% |
| 2001 Q1 | -2.2 Million AUD | 0.0% |
| 2001 Q3 | -1.86 Million AUD | 0.0% |
| 2001 Q4 | -1.86 Million AUD | 0.0% |
| 2001 FY | - AUD | 22.27% |
| 2001 Q2 | -1.86 Million AUD | 15.4% |
| 2000 Q2 | -2.2 Million AUD | 10.29% |
| 2000 Q4 | -2.2 Million AUD | 0.0% |
| 2000 Q3 | -2.2 Million AUD | 0.0% |
| 2000 FY | - AUD | 10.24% |
| 2000 Q1 | -2.45 Million AUD | 0.0% |
| 1999 Q4 | -2.45 Million AUD | 0.0% |
| 1999 Q2 | -2.45 Million AUD | -8.48% |
| 1999 Q3 | -2.45 Million AUD | 0.0% |
| 1999 Q1 | -2.26 Million AUD | 0.0% |
| 1999 FY | - AUD | -8.52% |
| 1998 Q2 | -2.26 Million AUD | -143.39% |
| 1998 Q3 | -2.26 Million AUD | 0.0% |
| 1998 Q1 | -931 Thousand AUD | 0.0% |
| 1998 Q4 | -2.26 Million AUD | 0.0% |
| 1998 FY | - AUD | -113.72% |
| 1997 Q3 | -931 Thousand AUD | 0.0% |
| 1997 FY | - AUD | 49.02% |
| 1997 Q4 | -931 Thousand AUD | 0.0% |
| 1997 Q2 | -931 Thousand AUD | 52.32% |
| 1997 Q1 | -1.95 Million AUD | 0.0% |
| 1996 Q4 | -1.95 Million AUD | 0.0% |
| 1996 Q3 | -1.95 Million AUD | 0.0% |
| 1996 FY | - AUD | -174.09% |
| 1996 Q2 | -1.95 Million AUD | -147.39% |
| 1996 Q1 | -789.25 Thousand AUD | 0.0% |
| 1995 FY | - AUD | -73.71% |
| 1995 Q1 | -354.5 Thousand AUD | 0.0% |
| 1995 Q2 | -789.25 Thousand AUD | -122.64% |
| 1995 Q3 | -789.25 Thousand AUD | 0.0% |
| 1995 Q4 | -789.25 Thousand AUD | 0.0% |
| 1994 Q4 | -354.5 Thousand AUD | 0.0% |
| 1994 Q2 | -354.5 Thousand AUD | -1503.96% |
| 1994 Q3 | -354.5 Thousand AUD | 0.0% |
| 1994 FY | - AUD | -185.57% |
| 1994 Q1 | 25.25 Thousand AUD | 0.0% |
| 1993 Q4 | 25.25 Thousand AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q2 | 25.25 Thousand AUD | 0.0% |
| 1993 Q3 | 25.25 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 1526.226% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -10058.668% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -306.073% |
| Biome Australia Limited | -1.57 Million AUD | -9276.054% |
| Patrys Limited | -3.49 Million AUD | -4137.434% |
| Orthocell Limited | -11.68 Million AUD | -1166.811% |
| Noxopharm Limited | -5.94 Million AUD | -2388.906% |
| PYC Therapeutics Limited | -38.11 Million AUD | -288.214% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -1209.562% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -1959.335% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -1776.146% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -1387.182% |
| CSL Limited | 4.73 Billion AUD | 103.127% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -1575.252% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -4874.059% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 385.325% |
| Starpharma Holdings Limited | -12.57 Million AUD | -1076.574% |
| Nanollose Limited | -1.14 Million AUD | -12791.152% |
| Memphasys Limited | -3.3 Million AUD | -4373.705% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -20439.873% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -8137.984% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -3145.411% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -963.106% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -5150.941% |
| Race Oncology Limited | -14.2 Million AUD | -941.849% |
| Nyrada Inc. | -4.59 Million AUD | -3119.564% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 744.334% |
| Dimerix Limited | -24.95 Million AUD | -492.894% |
| PharmAust Limited | -9.45 Million AUD | -1465.617% |
| Immutep Limited | -42.87 Million AUD | -245.136% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | -231.435% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -656.084% |
| BTC Health Limited | 1.05 Million AUD | 14122.504% |
| Acrux Limited | -7.93 Million AUD | -1765.813% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 174.263% |
| Biotron Limited | -5.04 Million AUD | -2836.033% |
| Tissue Repair Ltd | -5.77 Million AUD | -2462.386% |
| AdAlta Limited | -5.3 Million AUD | -2690.609% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | -226.113% |
| Hexima Limited | -995.54 Thousand AUD | -14764.015% |
| AnteoTech Limited | -11.57 Million AUD | -1178.87% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | -129.283% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -592.971% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -4463.676% |
| Actinogen Medical Limited | -12.92 Million AUD | -1045.234% |
| Immuron Limited | -6.19 Million AUD | -2289.682% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -7698.185% |